{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:27:11Z","timestamp":1769556431041,"version":"3.49.0"},"reference-count":57,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2024CXB023"],"award-info":[{"award-number":["2024CXB023"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Reports"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Head and neck squamous cell carcinoma (HNSCC), which constitutes approximately 90% of all head and neck cancers, represents a significant global health burden. A concerning trend is the rising incidence, particularly among younger populations, which has been partly attributed to human papillomavirus (HPV) infection. While treatment outcomes are favorable for early\u2010stage disease, approximately 60% of patients are diagnosed with locally advanced HNSCC (LA\u2010HNSCC), for whom prognosis remains suboptimal. Induction chemotherapy, such as the TPF regimen, is often used to reduce tumor burden but is limited by substantial toxicity. Currently, no global consensus exists on the optimal neoadjuvant approach for LA\u2010HNSCC. This network meta\u2010analysis aims to comprehensively compare the efficacy and safety of available neoadjuvant therapies for LA\u2010HNSCC, excluding nasopharyngeal carcinoma due to distinct treatment paradigms, in order to inform clinical decision\u2010making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To compare the efficacy and safety of different neoadjuvant treatment options in locally advanced head and neck squamous cell carcinoma (LA\u2010HNSCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p>\n                      We conducted a comprehensive literature search across four major databases (PubMed, Web of Science [WOS], Embase, and Cochrane Library) from their inception through August 2024. The primary outcome measures included objective response rate (ORR), overall survival (OS), progression\u2010free survival (PFS), and serious adverse events (SAEs). This analysis included 23 studies (19 randomized controlled trials [RCTs] and 4 non\u2010randomized studies [NRS]) involving 4052 patients. Network meta\u2010analysis (NMA) revealed the following findings: Regarding efficacy, hyperthermia + chemotherapy demonstrated superior outcomes in both ORR and OS, followed by immunotherapy + chemotherapy. Hyperthermia + chemotherapy showed significantly better ORR compared to targeted therapy + chemotherapy, TP, PF, T, and single\u2010agent immunotherapy (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Similarly, immunotherapy + chemotherapy outperformed all other therapies except hyperthermia + chemotherapy in ORR (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). For OS, both hyperthermia + chemotherapy and TPF were significantly more effective than PF and TP (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In PFS, immunotherapy + chemotherapy showed the best results, followed by targeted therapy + chemotherapy, with immunotherapy + chemotherapy being significantly superior to PF (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Regarding safety, hyperthermia + chemotherapy showed the poorest safety profile, followed by TPF. Specifically, T and TP demonstrated significantly better safety than hyperthermia + Chemotherapyy (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the neoadjuvant treatment of LA\u2010HNSCC, both hyperthermia + chemotherapy and immunotherapy + chemotherapy regimens have demonstrated promising therapeutic efficacy; however, their safety profiles require further comprehensive evaluation.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial Registration:<\/jats:bold>\n                      PROSPERO CRD42024571174\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cnr2.70447","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:45:33Z","timestamp":1769499933000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Different Neoadjuvant Treatment Regimens in Locally Advanced Squamous Head and Neck Cancer"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8638-9106","authenticated-orcid":false,"given":"Ya\u2010ting","family":"Ding","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Fujian Medical University  Fuzhou China"},{"name":"Department of Otolaryngology\u2010Head and Neck Surgery People's Hospital Affiliated of Quanzhou Medical College  Quanzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin\u2010bin","family":"Fang","sequence":"additional","affiliation":[{"name":"School of Physical Education, Quanzhou Normal University  Quanzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian\u2010bing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2010Head and Neck Surgery People's Hospital Affiliated of Quanzhou Medical College  Quanzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke\u2010jin","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2010Head and Neck Surgery People's Hospital Affiliated of Quanzhou Medical College  Quanzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li\u2010li","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2010Head and Neck Surgery Xiamen Medical College Affiliated Haicang Hospital, The Sixth Hospital of Xiamen City, The Haicang Hospital of Xiamen  Xiamen China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2010Head and Neck Surgery Xiamen Medical College Affiliated Haicang Hospital, The Sixth Hospital of Xiamen City, The Haicang Hospital of Xiamen  Xiamen China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun\u2010xia","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery The Second Affiliated Hospital of Nanchang University  Nanchang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5144-1637","authenticated-orcid":false,"given":"Geng\u2010ming","family":"Cai","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Fujian Medical University  Fuzhou China"},{"name":"Department of Otolaryngology\u2010Head and Neck Surgery Xiamen Medical College Affiliated Haicang Hospital, The Sixth Hospital of Xiamen City, The Haicang Hospital of Xiamen  Xiamen China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00224-3"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"issue":"2","key":"e_1_2_14_4_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/0022034519894963","article-title":"Incidence Trends of Lip, Oral Cavity, and Pharyngeal Cancers: Global Burden of Disease 1990\u20132017","volume":"99","author":"Du M.","year":"2019","journal-title":"Journal of Dental Research"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20998"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14654-z"},{"issue":"2","key":"e_1_2_14_7_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/odi.14450","article-title":"Changing Trend of Oral Cancer Disease Burden in China From 1990 to 2019 and the Forecast for the Next 20\u2009Years","volume":"30","author":"Xie L.","year":"2022","journal-title":"Oral Diseases"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6239"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.10.014"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.043"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.05.010"},{"key":"e_1_2_14_12_1","volume-title":"Head and Neck Cancer Guidelines of Chinese Society of Clinical Oncology (CSCO)","author":"Guidelines Working Committee of Chinese Society of Clinical Oncology","year":"2022"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106133242402"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.13.890"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189294"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.06.049"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08128-5"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13205"},{"key":"e_1_2_14_20_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2021.03.051","article-title":"Docetaxel, Cisplatin and 5\u2010FU Compared With Docetaxel, Cisplatin and Cetuximab as Induction Chemotherapy in Advanced Squamous Cell Carcinoma of the Head and Neck: Results of a Randomised Phase II AGMT Trial","volume":"151","author":"Keil F.","year":"2021","journal-title":"European Journal of Cancer"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.382"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00136-4"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3351"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1695"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002568"},{"issue":"355","key":"e_1_2_14_26_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS\u2010I: A Tool for Assessing Risk of Bias in Non\u2010Randomised Studies of Interventions","volume":"355","author":"Sterne J. A.","year":"2016","journal-title":"BMJ"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9868.00353"},{"issue":"4","key":"e_1_2_14_28_1","first-page":"335","article-title":"Phase II Clinical Trial of PD\u20101 Inhibitor Combined With Chemotherapy for Locally Advanced Resectable Oral Squamous Cell Carcinoma","volume":"59","author":"Wang H. L.","year":"2024","journal-title":"Chinese Journal of Otorhinolaryngology Head and Neck Surgery"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113560"},{"issue":"16","key":"e_1_2_14_30_1","article-title":"De\u2010Escalation Treatment of Patients with HPV\u2010Positive Oropharyngeal Squamous Cell Carcinoma","volume":"42","author":"Golubev P.","year":"2024","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05497-1"},{"key":"e_1_2_14_32_1","article-title":"895P Neoadjuvant PD\u20101 Inhibitor Combined With Nab\u2010Paclitaxel and Cisplatin in Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT05522985): A Randomized, Controlled, Open Label, Phase II Clinical Trial","volume":"34","author":"Wang H.","year":"2023","journal-title":"Annals of Oncology"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2022.100177"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.07.034"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2021.1937714"},{"issue":"4","key":"e_1_2_14_36_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12032-021-01479-w","article-title":"Nab\u2010Paclitaxel and Cisplatin Followed by Cisplatin and Radiation (Arm 1) and Nab\u2010Paclitaxel Followed by Cetuximab and Radiation (Arm 2) for Locally Advanced Head and Neck Squamous\u2010Cell Carcinoma: A Multicenter, Non\u2010Randomized Phase 2 Trial","volume":"38","author":"Oppelt P.","year":"2021","journal-title":"Medical Oncology"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13252"},{"issue":"4","key":"e_1_2_14_38_1","article-title":"Long\u2010Term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5\u2010Fluorouracil, \u00b1 Docetaxel for Larynx Preservation","volume":"108","author":"Janoray G.","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0208"},{"issue":"1","key":"e_1_2_14_40_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/0019-509X.175601","article-title":"A Prospective Study to Assess the Efficacy and Toxicity of 5\u2010Flurouracil and Cisplatin Versus Taxane and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Cancer in a Regional Cancer Center in India","volume":"52","author":"Rudresha A.","year":"2015","journal-title":"Indian Journal of Cancer"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2011.01306.x"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70279-5"},{"issue":"7","key":"e_1_2_14_43_1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized Trial of Induction Chemotherapy With Cisplatin and 5\u2010Fluorouracil With or Without Docetaxel for Larynx Preservation","volume":"101","author":"Pointreau Y.","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071028"},{"issue":"3","key":"e_1_2_14_45_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s002620050515","article-title":"Neo\u2010Adjuvant Chemo\u2010(Immuno\u2010)therapy of Advanced Squamous\u2010Cell Head and Neck Carcinoma: A Multicenter, Phase III, Randomized Study Comparing Cisplatin + 5\u2010Fluorouracil (5\u2010FU) With Cisplatin + 5\u2010FU + Recombinant Interleukin 2","volume":"47","author":"Mantovani G.","year":"1998","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21785"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.1990"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.02.019"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.01.016"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1715715"},{"key":"e_1_2_14_52_1","article-title":"Treatment Choice for Locally Advanced Head and Neck Cancers on the Basis of Risk Factors: Biological Risk Factors","volume":"23","author":"Braakhuis B. J. M.","year":"2012","journal-title":"Annals of Oncology"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861015)58:8<1589::AID-CNCR2820580802>3.0.CO;2-B"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.12.361"},{"issue":"2","key":"e_1_2_14_55_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1994.45","article-title":"Response of Peritoneal Solid Tumours After Intraperitoneal Chemohyperthermia Treatment With Cisplatin or Carboplatin","volume":"69","author":"Los G.","year":"1994","journal-title":"British Journal of Cancer"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf280"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000257"},{"key":"e_1_2_14_58_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106479","article-title":"Neoadjuvant PD\u20101\/PD\u2010L1 Inhibitors Combined With Chemotherapy Had a Higher ORR Than Mono\u2010Immunotherapy in Untreated HNSCC: Meta\u2010Analysis","volume":"145","author":"Chen S.","year":"2023","journal-title":"Oral Oncology"}],"container-title":["Cancer Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.70447","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cnr2.70447","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.70447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:11:50Z","timestamp":1769508710000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cnr2.70447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1002\/cnr2.70447"],"URL":"https:\/\/doi.org\/10.1002\/cnr2.70447","archive":["Portico"],"relation":{},"ISSN":["2573-8348","2573-8348"],"issn-type":[{"value":"2573-8348","type":"print"},{"value":"2573-8348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70447"}}